Aurinia Pharmaceuticals
AUPH
AUPH
72 hedge funds and large institutions have $136M invested in Aurinia Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
30% less capital invested
Capital invested by funds: $193M → $136M (-$57.1M)
Holders
72
Holding in Top 10
–
Calls
$8.66M
Puts
$8.18M
Top Buyers
| 1 | +$4.45M | |
| 2 | +$2.77M | |
| 3 | +$2.71M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$1.42M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$802K |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$11.6M | |
| 3 | -$8.87M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.04M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$852K |